I really doubt the opt out idea would work well. Companies that make cheap knock offs don't produce anything unique, and as such would always opt out. Take th

I really doubt the opt out idea would work well. Companies that make cheap knock offs don't produce anything unique, and as such would always opt out. Take the drug industry for instance, all your generics manufactures never do blue sky new drug research. They would always opt out. This makes it useless for companies that do perform blue sky research to opt in.